Study identifier:D3250C00100
ClinicalTrials.gov identifier:NCT06427876
EudraCT identifier:N/A
CTIS identifier:N/A
FASENRA® Subcutaneous Injection 30 mg / 10mg Syringe Protocol of Specific drug use result study for pediatric patients
Bronchial Asthma
N/A
No
-
All
40
Observational
n/a - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|